EV/EBITDA:
-3.85+0.11(+2.78%)Summary
- As of today (August 3, 2025), DNLI EV/EBITDA is -3.85, with a rise of +0.11 (+2.78%) during the most recent trading session on August 1, 2025.
- Over the past year, DNLI EV/EBITDA has increased by +2.74 (+41.58%).
- DNLI EV/EBITDA is now -102.05% below its all-time high of 187.57.
Performance
DNLI EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
DNLI EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +2.8% | -2.8% | -2.8% |
| 1 m1 month | +3.8% | -3.7% | -3.7% |
| 3 m3 months | +16.3% | -16.4% | -16.3% |
| 6 m6 months | +41.3% | -39.9% | -42.3% |
| ytdytd | +32.6% | -30.9% | -34.0% |
| 1 y1 year | +41.6% | -39.4% | -42.4% |
| 5 y5 years | +64.7% | -19.5% | -42.6% |
DNLI EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -3.85 | at high | -4.40 | +12.5% |
| 3 m | 3-month | -3.73 | -3.2% | -4.71 | +18.3% |
| 6 m | 6-month | -3.28 | -17.4% | -6.65 | +42.1% |
| 1 y | 1-year | -3.28 | -17.4% | -9.09 | +57.6% |
| 3 y | 3-year | -3.28 | -17.4% | -29.56 | +87.0% |
| 5 y | 5-year | 187.57 | -102.0% | -47.42 | +91.9% |
| alltime | all time | 187.57 | -102.0% | -58.31 | +93.4% |
DNLI EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.85(-32.6%) |
| 2024 | -5.71(-64.3%) |
| 2023 | -15.99(+45.8%) |
| 2022 | -10.97(-39.7%) |
| Date | Value |
|---|---|
| 2021 | -18.19(-113.4%) |
| 2020 | 135.54(-1767.2%) |
| 2019 | -8.13(-83.1%) |
| 2018 | -48.22(+265.0%) |
| 2017 | -13.21 |
FAQ
- What is Denali Therapeutics Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Denali Therapeutics Inc.?
- What is DNLI EV/EBITDA year-to-date change?
- What is Denali Therapeutics Inc. EV/EBITDA year-on-year change?
What is Denali Therapeutics Inc. EV/EBITDA?
The current EV/EBITDA of DNLI is -3.85
What is the all time high EV/EBITDA for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high EV/EBITDA is 187.57
What is DNLI EV/EBITDA year-to-date change?
Denali Therapeutics Inc. EV/EBITDA has changed by +1.86 (+32.57%) since the beginning of the year
What is Denali Therapeutics Inc. EV/EBITDA year-on-year change?
Over the past year, DNLI EV/EBITDA has changed by +2.74 (+41.58%)